Core Insights - The article discusses the significant growth of China's innovative pharmaceuticals, projecting over $136 billion in cross-border transaction value by 2025, marking a shift from "single-point innovation" to "global value supply" [2] - The event aims to analyze the latest trends in cross-border licensing and M&A transactions, focusing on the ADC and oncology asset export logic, as well as the competitive landscape in the GLP-1 commercialization path [2] - The discussion will also cover the latest regulatory developments in the industry and the transformative potential of artificial intelligence in drug development, pipeline efficiency, and valuation frameworks [2] Event Details - The Bloomberg Pharmaceutical Market Insight Conference is scheduled for March 10, 2026, in Shanghai, featuring industry leaders and Bloomberg experts [2][3] - The agenda includes keynote speeches, panel discussions on future M&A technology routes, and interactive exchanges [3] Speakers - Notable speakers include executives from major companies such as China Biopharmaceutical Co., AbbVie China, and Bloomberg Industry Research, highlighting the expertise present at the event [4]
活动邀请 | 彭博制药业市场洞察会：领航全球管线——中国创新药的新估值
彭博Bloomberg·2026-02-05 06:06